Abstract Details

Title A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 3 Trial to Determine the Efficacy and Safety of Ganaxolone as Adjunctive Therapy for Adults with Drug-Resistant Focal-Onset Seizures

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P5 - (-)

Poster/Presentation
Number 237

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Jaakko Lappalainen, MD, PhD (Marinus) PRESENTER	No disclosure on file
Julia Tsai (Marinus Pharmaceuticals, Inc)	No disclosure on file
	No disclosure on file
Albena I. Patroneva, MD (Harmony Biosciencesw)	Dr. Patroneva has nothing to disclose.